glp 1 news A wave of new #GLP1 drug options for type 2 #Diabetes and #Obesity was a major focus at #ADA2026. In the latest JAMA Medical podcast, Jennifer Abbasi interviews Rita Kalyani, MD GLP-1 demand surges. Here's how

Findings In total, 99 individuals were recruited and invited to complete the three-day food record

People think they should be able to control this with willpower, he says

Other Innovative Solutions To further support our clients and their members, we created our Diabetes Care Plus program

More GLP-1 was needed to have the same biological effect, meaning they were resistant to GLP-1. Seeking confirmation The results were so surprising, Gloyns team spent the next several years confirming them

Treating these conditions poses a high economic burden

Rocio Pereira, MD, chief of Endocrinology at the safety-net hospital system Denver Health and an associate professor of medicine at the University of Colorado, says that many of her patients report that semaglutide helps them eat less and that it has become easier for them to eat healthy foods and avoid junk food since starting on the medication